Endpoints News 2026년 1월 8일 FDA staff cuts mostly didn't impact new drug review timelines, analysis finds
Endpoints News 2026년 1월 8일 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News 2026년 1월 8일 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Endpoints News 2026년 1월 8일 Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C
Endpoints News 2026년 1월 8일 Former Genentech leaders’ protein degrader startup EpiBiologics nets $107M
Endpoints News 2026년 1월 7일 Immuneering’s pancreatic cancer pill continues to beat standard care, updated first line data show